Radiation treatment for patients with intermediate-risk prostate cancer.
Around 70% of men presenting with prostate cancer will have organ-confined disease, with the majority presenting with low- or intermediate-risk prostate cancer. This article reviews the evidence supporting the current standard of care in radiation oncology for the evaluation and management of men with intermediate-risk prostate cancer. Dose escalation, hormonal therapy, combined modality therapy, and modern techniques for the delivery of radiation therapy are reviewed.
Lieutenant Commander, 4501 X st, Radiation Oncology, Sacramento, CA 95817, USA.
David E
DE
Greene
Jyoti S
JS
Mayadev
Richard K
RK
Valicenti